Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA216691
Max Phase: Preclinical
Molecular Formula: C62H70Cl2N2O16
Molecular Weight: 1170.15
Molecule Type: Small molecule
Associated Items:
ID: ALA216691
Max Phase: Preclinical
Molecular Formula: C62H70Cl2N2O16
Molecular Weight: 1170.15
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)O[C@H]1C(=O)[C@@]2(C)C([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2OCOC(=O)CCCc1ccc(N(CCCl)CCCl)cc1
Standard InChI: InChI=1S/C62H70Cl2N2O16/c1-37-45(80-58(74)51(70)50(41-18-10-7-11-19-41)65-56(72)42-20-12-8-13-21-42)34-62(75)55(81-57(73)43-22-14-9-15-23-43)53-60(6,54(71)52(79-38(2)67)49(37)59(62,4)5)46(33-47-61(53,35-76-47)82-39(3)68)77-36-78-48(69)24-16-17-40-25-27-44(28-26-40)66(31-29-63)32-30-64/h7-15,18-23,25-28,45-47,50-53,55,70,75H,16-17,24,29-36H2,1-6H3,(H,65,72)/t45-,46-,47+,50-,51+,52+,53?,55-,60+,61-,62+/m0/s1
Standard InChI Key: ZQWBNQBOFOQEGM-MKEVXUACSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1170.15 | Molecular Weight (Monoisotopic): 1168.4102 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wittman MD, Kadow JF, Vyas DM, Lee FL, Rose WC, Long BH, Fairchild C, Johnston K.. (2001) Synthesis and antitumor activity of novel paclitaxel-chlorambucil hybrids., 11 (6): [PMID:11277526] [10.1016/s0960-894x(01)00067-1] |
Source(1):